EP Patent

EP2654757A1 — The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents

Assigned to Entarco SA · Expires 2013-10-30 · 13y expired

What this patent protects

The present invention relates to the use of spinosyns and spinosyn compositions as local anesthetics and antiarrhythmic agents. Advantageously, spinosyns may be used as local anesthetics and/or antiarrhythmic agents with little or no disruption or harm to the host which may be an…

USPTO Abstract

The present invention relates to the use of spinosyns and spinosyn compositions as local anesthetics and antiarrhythmic agents. Advantageously, spinosyns may be used as local anesthetics and/or antiarrhythmic agents with little or no disruption or harm to the host which may be an animal or human.

Drugs covered by this patent

Patent Metadata

Patent number
EP2654757A1
Jurisdiction
EP
Classification
—
Expires
2013-10-30
Drug substance claim
No
Drug product claim
No
Assignee
Entarco SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.